Acadia Pharmaceuticals INC
SEC CIK 1070494 · ACAD · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baker Julian | Director | filed 2012 - 2026 |
| Baker Felix | Director | filed 2012 - 2026 |
| Baker Bros. Advisors LP | Director | filed 2012 - 2026 |
| Baker Brothers Life Sciences LP | Director | filed 2013 - 2026 |
| 667, L.P. | Director | filed 2013 - 2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2013 - 2026 |
| Harrigan Edmund | Director | filed 2015 - 2026 |
| Brege Laura | Director | filed 2008 - 2026 |
| Daly James M | Director | filed 2016 - 2026 |
| Poole Jonathan | Director | filed 2026 - 2026 |
| Garofalo Elizabeth A. | Director | filed 2020 - 2026 |
| Ndu Adora | Director | filed 2022 - 2026 |
| Owen Catherine E. | Director · Chief Executive Officer | filed 2024 - 2026 |
| Soland Daniel B | Director | filed 2015 - 2025 |
| Davis Stephen | Director · President and CEO | filed 2014 - 2024 |
| 14159, L.P. | Director | filed 2013 - 2018 |
| Gray Mary ANN | Director | filed 2006 - 2016 |
| Iversen Leslie L | Director | filed 2006 - 2016 |
| Kaplan Lester J PH D | Director | filed 2006 - 2015 |
| Borer Michael T | Director | filed 2006 - 2015 |
| Rasmussen Torsten | Director | filed 2006 - 2015 |
| Wells William Mcdowall | Director | filed 2012 - 2015 |
| Hacksell Uli | Director · CEO | filed 2006 - 2015 |
| Biggar Stephen R | Director | filed 2013 - 2013 |
| Walton Alan G | Director | filed 2006 - 2009 |
| Binder Gordon M | Director | filed 2006 - 2009 |
| Brann Mark R | Director · President, Chf. Sci. Officer | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kihara James | Principal Accounting Officer | filed 2020 - 2026 |
| Schneyer Mark C. | EVP, Chief Financial Officer | filed 2021 - 2026 |
| Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | filed 2024 - 2026 |
| Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | filed 2024 - 2026 |
| Garner Thomas | EVP, Chief Commercial Officer | filed 2024 - 2026 |
| Teehan Brendan | EVP, COO, Head of Commercial | filed 2021 - 2024 |
| KIM Austin D. | EVP,General Counsel, Secretary | filed 2018 - 2024 |
| Williamson Douglas J | Executive VP, Research & Dev | filed 2023 - 2023 |
| Stankovic Srdjan R. | President | filed 2015 - 2022 |
| Ridloff Elena | EVP and CFO | filed 2019 - 2021 |
| Yang Michael J. | EVP and CCO | filed 2017 - 2021 |
| Miller Eric Alejandro | Controller & PAO | filed 2018 - 2019 |
| Young Todd S. | EVP AND CFO | filed 2016 - 2018 |
| Baity Glenn | VP, GC & Sec. | filed 2010 - 2018 |
| Moore Terrence O | EVP, CHIEF COMMERCIAL OFFICER | filed 2013 - 2017 |
| Mills Roger | Executive VP, Development | filed 2006 - 2015 |
| Aasen Thomas H | Vice Pres., CFO, Treas. & Sec. | filed 2006 - 2014 |
| Tolf Bo-Ragnar | VP/Mg. Dir. ACADIA Pharma AB | filed 2006 - 2009 |
| Kaiser John Joseph | VP, Strat. Mrkting & Com. Dev. | filed 2008 - 2008 |
| Lundstrom Brian | Sr. VP, Bus. Devt. | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.